Severe myoclonic epilepsy of infancy (SMEI) is a complex form of epilepsy that was first
described in France in 1978. Because the myoclonic component of this epilepsy is not�…

Severe myoclonic epilepsy in infancy (SMEI) is a rare disease, characterized by febrile and
afebrile, generalized and unilateral, clonic or tonic–clonic seizures that occur in the first year�…

Severe Myoclonic Epilepsy in infancy (SMEI, or Dravet syndrome) is a drug‐resistant
epilepsy that occurs in the first year of life of previously healthy children. The main clinical�…

To report the authors' experience with diagnosis and management of Dravet syndrome, or
severe myoclonic epilepsy in infancy, in the era of commercially available genetic testing�…

Dravet syndrome (DS), previously known as severe myoclonic epilepsy in infancy (SMEI), is
an epileptic encephalopathy that presents with prolonged seizures in the first year of life�…

Severe myoclonic epilepsy of infancy (SMEI or Dravet syndrome) is a rare disorder occurring
in young children often without a family history of a similar disorder. The earliest disease�…

Introduction: To determine the occurrence of neuroradiological abnormalities and to perform
genotype–phenotype correlations in severe myoclonic epilepsy of infancy (SMEI, Dravet�…

Severe myoclonic epilepsy of infancy (SMEI) or Dravet syndrome is a rare epilepsy
syndrome. In 30 to 70% of SMEI patients, truncating and missense mutations in the neuronal�…

Introduction: Mutations in the voltage-gated sodium channel SCN1A gene are the main
genetic cause of Dravet syndrome (previously called severe myoclonic epilepsy of infancy or�…

PURPOSE: Aim of this study is to report a detailed profile of neuropsychological
development in children with Dravet syndrome. METHODS: Twelve children with Dravet�…